GNS.L Stock - Genus plc
Unlock GoAI Insights for GNS.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $672.80M | $668.80M | $689.70M | $593.40M | $574.30M |
| Gross Profit | $672.80M | $178.70M | $239.30M | $226.00M | $232.20M |
| Gross Margin | 100.0% | 26.7% | 34.7% | 38.1% | 40.4% |
| Operating Income | $42.40M | $6.40M | $40.50M | $56.60M | $61.50M |
| Net Income | $19.30M | $7.90M | $33.30M | $40.90M | $47.30M |
| Net Margin | 2.9% | 1.2% | 4.8% | 6.9% | 8.2% |
| EPS | $0.29 | $0.12 | $0.51 | $0.63 | $0.73 |
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in reproductive, and other technical services to farmers. Genus plc has a strategic collaboration with Beijing Capital Agribusiness Co. Ltd to pursue the porcine reproductive respiratory syndrome virus resistant regulatory and development work in China. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
Visit WebsiteEarnings History & Surprises
GNS.LEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 25, 2026 | — | — | — | — |
Q1 2025 | Feb 27, 2025 | — | $0.02 | — | — |
Q3 2024 | Sep 5, 2024 | — | $-0.08 | — | — |
Q2 2024 | Apr 30, 2024 | $0.33 | $0.20 | -38.0% | ✗ MISS |
Q3 2023 | Sep 7, 2023 | — | $0.30 | — | — |
Q1 2023 | Feb 23, 2023 | — | $0.20 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.32 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.30 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.24 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.48 | — | — |
Q2 2020 | Jun 30, 2020 | $0.42 | $0.26 | -39.5% | ✗ MISS |
Q4 2019 | Dec 31, 2019 | $0.39 | $0.36 | -7.3% | ✗ MISS |
Q2 2019 | Jun 30, 2019 | — | $0.23 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.12 | — | — |
Q2 2018 | Jun 30, 2018 | — | $0.01 | — | — |
Q4 2017 | Dec 31, 2017 | — | $0.68 | — | — |
Q2 2017 | Jun 30, 2017 | — | $0.40 | — | — |
Q4 2016 | Dec 31, 2016 | — | $0.13 | — | — |
Q2 2016 | Jun 30, 2016 | — | $0.63 | — | — |
Q4 2015 | Dec 31, 2015 | — | $0.17 | — | — |
Latest News
Frequently Asked Questions about GNS.L
What is GNS.L's current stock price?
What is the analyst price target for GNS.L?
What sector is Genus plc in?
What is GNS.L's market cap?
Does GNS.L pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to GNS.L for comparison